Skip to content

SEARCH

Trade Alerts
Investing
Market News
Biotech
Oil & Gas
Mining
Gaming
Technology
Crypto
More
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Food & Beverage
- Industrials

Search

SEARCH FOR AN ARTICLE

Search

Trade Alerts
Investing
Market News
Biotech
Oil & Gas
Mining
Gaming
Technology
Crypto
More
- Health
- Entertainment
- Real Estate
- Cannabis
- ESG
- Financial
- Food & Beverage
- Industrials

HomeHealth

Health

TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant

TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant

January 21, 2025

« 1 … 49 50 51

LATEST NEWS

Investing News Anthropic’s Explosive Growth and IPO
Investing News Japan Megabanks’ Profit Surge Amid Risks
Investing News Walmart’s Q1 2027 Earnings Surge
Investing News Workday Q1 Earnings Report 2027

Bull Stock Research

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Bull Stock Research.

I want e-mail alerts, updates, and offers and agree to the Bull Stock Research privacy policy.

Market Jar Media Inc. © 2026